Health24.com | Are DIY sunscreens dangerous?

Interest in homemade sunscreens is hot, but many of these do-it-yourself brews lack effective sun protection, a new study warns.

Researchers found that only about one-third of homemade sunscreens on the popular information-sharing website Pinterest specified how much sun protection factor (SPF) each “natural” sunblock contained. In some cases, SPF content dipped as low as 2 – far below recommended guidelines for preventing premature ageing and skin cancer.

True broadband protection

Overall, about seven out of 10 sunscreen recipes failed to adequately protect skin from dangerous ultraviolet (UV) rays, the study authors found.

“It is a great sign that consumers are paying attention to what is in their products,” said study author Julie Merten. She is an associate professor with the University of North Florida’s Brooks College of Health.

But she and her colleagues are cautioning do-it-yourselfers to be mindful that if “they do use Pinterest to make their own sunscreen, to be sure it is a formula that offers true broadband protection”.

Unlike commercial sunscreens, the Pinterest recipes aren’t tested or regulated, and could cause harm, Merten and others said.

Merten acknowledged there are “legitimate concerns” about some commercial sunscreens, including reef habitat destruction and hormone-disrupting chemicals. These “align with a societal shift toward more natural and organic products”, she noted.

Recently, a study from the University of California, San Francisco (UCSF), raised concerns regarding four common commercial-sunscreen chemicals: oxybenzone, avobenzone, octocrylene and ecamsule.

Anti-cancer and anti-ageing benefits

All four chemicals were found to have entered the users’ bloodstreams at levels far exceeding US Food and Drug Administration safety thresholds.

Still, the UCSF study team did not conclude that anyone’s health was at risk. And some experts believe any concerns that might be raised are outweighed by the anti-cancer and anti-ageing benefits of FDA-approved sunscreens.

One of those experts is Dr Steven Wang, director of dermatology at Memorial Sloan Kettering Cancer Center, in Basking Ridge, New Jersey.

“There’s tons of scientific data that sunscreen with SPF of at least 15 reduces the risk for both melanomas and squamous cell cancer, and prevents wrinkles and pigmentation. That’s the benefit,” said Wang.

“But in terms of why people would even think about making a sunscreen at home, I think that is probably based less on science than on fear,” he said.

These are not easy products to make, according to Wang, who is also chair of the Skin Cancer Foundation’s photobiology committee. “Some of the filters they contain are water-soluble, while others are oil-soluble. So molecules can separate, and the end result won’t deliver the protection you’re after. You can’t just whip it together,” he explained.

SPF of 15 or more

Using a do-it-yourself sunscreen that doesn’t work could be more dangerous than using nothing at all, he warned. That’s because “when you put oil on your skin without any blockers, you actually allow the UV rays to penetrate deeply into your skin,” Wang said.

Merten said that could make users vulnerable to sunburn.

The bottom-line? People should be “very thorough in their research if they decide to use homemade sunscreens, and to use ingredients such as zinc and titanium oxide with proven UV blocking ability,” Merten said.

The FDA recommends sunscreens with an SPF of 15 or more, while the American Academy of Dermatology’s recommended minimum is SPF 30.

Most experts advise applying sunscreen a half hour before heading outdoors. Reapply at least every two hours, more often if you’re swimming or sweating.

The report was published in Health Communication.

Image credit: iStock

Share Button

General election 2019: How many ‘new’ NHS hospitals are Conservatives building?

It’s not six completely new hospitals – some involve redeveloping existing buildings and sites.

Share Button

Health24.com | New UNAIDS head visits Soshanguve

The new Executive Director of the Joint United Nations Programme on HIV/AIDS (UNAIDS) Winnie Byanyima was in Soshanguve, a township north of Pretoria, on Friday for a clinic visit, a town hall engagement with the local community, and to partake in activities of a new civil society clinic monitoring project called Ritshidze.

The visit was one of Byanyima’s first engagements as head of UNAIDS and came two days ahead of World AIDS Day.

Byanyima (60) hails from Uganda and is an experienced diplomat and activist. Prior to starting in the UNAIDS top job in November, she was the executive director of Oxfam International. Before that she served as director of gender and development at the UN Development Programme.

Her recent appointment at UNAIDS was widely welcomed among activists, particularly gender activists unhappy with the handling of allegations of sexual harassment at UNAIDS under her predecessor Michelle Sidibé.

Communities matter

After a visit to a clinic in Soshanguve Byanyima was impressed with how the community is taking charge of what they need. “The theme of this report this year is that communities matter; that we must invest in communities and that it is communities that make things happen for their people and that is what I’ve found here.”

She said the community served by this clinic is helping the health professionals to give them what they need. “Because it is communities who know what they need and it is communities who need to supervise and speak out and demand from duty bearers to deliver.

That is important.”The Ritshidze project is a new community-led monitoring and accountability initiative of HIV and TB services in high burden public healthcare facilities in South Africa. On Friday Byanyima had first-hand experience of how this project works.

Byanyima observed that she found a clinic that works despite challenges.  She praised healthcare workers for their creativity in handling these challenges. “[They] turned a toilet into a consulting room; removed the toilet and kept the sink and even though there is no bed here, there’s space for a patient to be examined – so, it is still working.”

She noted that challenges around space and staff shortages result in long queues and waiting times. “And this is the type of things the community is noting in their monitoring forms. So, this gives me hope that people can speak and be heard.”

She also stressed the importance of communities asserting themselves as rights claimants and making it clear to dutybearers that they are checking on them.

Testimonies

After the clinic visit Byanyima heard testimony from local community members who gathered in the Halala community centre hall in Block H in Soshanguve. These included reports of multiple service delivery failures in public sector clinics and hospitals – the type of issues the newly launched Ritshidze clinic monitoring  project wants to change.

People reported long waiting times – sometimes arriving at clinics at 04:00 in the morning and only leaving 12 hours later. Some people reported bad attitudes from nurses as well as from security guards and cleaners. Worse still some said, is the inefficiency and unprofessional conduct from nurses that has compromised their healthcare.

People also spoke about intermittent stock-outs, non-functioning and dirty toilets and emergency services that never arrive on time, if at all.Senior representatives of the Department of Health accompanied Byanyima to the clinic but did not attend the community meeting.  

A TAC member who stood up to tell her story, declared how she is living her life positively on treatment but also highlighted the fact that she knows she gets better treatment because she’s a community activist.Others are not so lucky.

One 35-year-old women’s testimony silenced the hall. As she spoke her voice cracked and her eyes filled with tears. She said that she is HIV positive and a single, unemployed mother to two teenagers. She developed an anal abscess in 2017 that has resulted in two botched operations. Now her life is ruined and she says she has little hope for her future.

Goodness Mbatha, a community monitor from the Ritshidze Project, who met the woman during a door-to-door campaign in January, said  the woman was diagnosed with HIV in 2006 and she knows that her daughter who washes her and cleans the unhealed sores is at risk of infection.

“She wants so little – some pads from the hospital, maybe even some gloves so that she can minimise HIV infection risks,” said Mbatha. Vionne Visagie, a woman living in Winterveld, also raised her hand to speak in the hall.

She said: “I am not HIV positive but I’m living positively with HIV”.  It brought on claps and cheers of “Yes Girl!” from the audience. Visagie (32) spoke to Spotlight after the dialogue. She said standing up in a hall and giving a positive message is important. She has felt that way since she was diagnosed with HIV 13 years ago.  She found out her status a year after her son was born.

Though he was born HIV negative, she believes that she contracted HIV from a boyfriend at the time and her son contracted the virus through her breast milk. “This is the part that is difficult for me. My son developed problems from the HIV and he had something like a stroke so he’s not alright and lives with my granny in Shoshanguve now. Every time I look at him, I think ‘if only’. People don’t understand that pain,” Visagie said.

“What hurts me most is that the neighbours wouldn’t let the other children play with my child and even now he gets sick from pneumonia all the time and I can get a phone call at 2 or 3am from my granny saying she’s at the hospital. Every time I think maybe it is going to be his last day.” 

Sibongile Tshabalala, TAC chairperson, who facilitated the dialogue, said: “People think we are exaggerating when we hear these stories but this is how people living with HIV are being made to lose their dignity… it is difficult to hold back our tears.”

In solidarity

Byanyima pledged solidarity as she addressed the community at the end of the dialogue. She said her report will focus on communities, in recognition of the fact that community courage and action is what pushes back ineffective governments and weak leadership.

“It’s also communities that know best what people need,” she added.“I have come here today and I see you standing up and I salute you and I praise you – keep doing what you are doing,” Byanyima said.

She said that patients should not be treated like they had to grovel for decent care from service providers and access to life saving therapies.

Byanyima also had a word for the people who shared their stories of living with HIV/Aids.

“I have seen people crying I have seen your pain – this is a struggle for life but you are the heroes who are speaking out against stigma,” she said. The event was organised by the Ritshidze project, a new community-led monitoring and accountability initiative of HIV and TB services in high burden public healthcare facilities in South Africa.

The project is a collaboration between the Treatment Action Campaign (TAC), Positive Action Campaign (PAC), Positive Women’s Network (PWN), the National Association of People Living with HIV and AIDS (NAPWA), and the South African Network of Religious Leaders living with or Affected by HIV and AIDS (SANERELA+).

Other partners include Health GAP, amfAR, and Georgetown University’s O’Neill Institute.

*Note: The TAC is mentioned in this article. Spotlight is published by SECTION27 and the TAC but is editorially independent – independence that the editors guard jealously. Spotlight is a member of the South African Press Council.

*This article was produced by Spotlight – health journalism in the public interest.

Image credit: Denvor De Wee, Spotlight

Share Button

Health24.com | Major study shows vaping is less harmful than smoking for your heart

Vaping has been the topic of many controversial headlines – but the dangers of this relatively new practice are not yet as clear as those of traditional combustible tobacco products.

Yet, experts claim that vaping is significantly less harmful than cigarette smoking. And now, a major study conducted by the University of Dundee concluded that cigarette smokers who switch to nicotine-containing vaporisers could significantly improve their vascular health.

The two-year trial hosted by the university’s Medicine School, found that the smokers who switched to vaping products such as e-cigarettes showed significant improvement in their vascular health after only four weeks, according to an news article.

This study also found that those smokers who transferred to vaping only had better health compared to those who used both tobacco cigarettes and e-cigarettes (also referred to as dual usage).

The findings were published in the Journal of the American College of Cardiology and this study has been the largest undertaken to date to determine the implication of heart health.

Not 100% safe

But, this optimistic outcome comes with a caveat, which should be emphasised to avoid any misunderstanding.

Professor Jacob George, Professor of Cardiovascular Medicine and Therapeutics at Dundee and Chief Investigator of the trial, said that even though vaping is considered less harmful, it is not 100% safe and may still carry health risks:

“It is crucial to emphasise that e-cigarettes are not safe, just less harmful than tobacco cigarettes when it comes to vascular health. Smoking of any kind is a preventable risk factor for heart disease.

“They should not be seen as harmless devices for non-smokers or young people to try. However, for chronic tobacco smokers there were significant improvements in vascular function within a month of switching from a tobacco cigarette to an e-cigarette.

Fewer harmful chemicals

“To put into context, each percentage point improvement in vascular function results in a 13% reduction in cardiovascular event rates such as heart attack. By switching from cigarettes to e-cigarettes we found an average percentage point improvement of 1.5 within just one month. This represents a significant improvement in vascular health. We also found that, in the short term at least, regardless of whether the e-cigarette does or does not contain nicotine, a person will see vascular health improvements compared to smoking a traditional cigarette. The longer term impact of nicotine requires further study and follow-up.”

Professor Jeremy Pearson, Associate Medical Director at the British Heart Foundation, said the following in a news report: “Our hearts and blood vessels are the hidden victims of smoking. Every year in the UK, 20 000 people die from heart and circulatory disease caused by smoking cigarettes – that’s more than 50 people a day, or two deaths every hour. Stopping smoking is the single best thing you can do for your heart health.

“This study suggests that vaping may be less harmful to your blood vessels than smoking cigarettes. Within just one month of ditching tobacco for electronic cigarettes, people’s blood vessel health had started to recover.

“Just because e-cigarettes may be less harmful than tobacco doesn’t mean they are completely safe. We know they contain significantly fewer of the harmful chemicals, which can cause diseases related to smoking, but we still don’t know the long term impact on the heart and circulation, or other aspects of health. E-cigarettes and vaping should never be taken up by people who don’t already smoke, but could be a useful tool to help people to stop smoking completely.”

Image credit: iStock

Share Button

A common drug could help restore limb function after spinal cord injury

Long-term treatment with gabapentin, a commonly prescribed drug for nerve pain, could help restore upper limb function after a spinal cord injury, new research in mice suggests.

In the study, mice treated with gabapentin regained roughly 60 percent of forelimb function in a skilled walking test, compared to restoration of approximately 30 percent of forelimb function in mice that received a placebo.

The drug blocks activity of a protein that has a key role in the growth process of axons, the long, slender extensions of nerve cell bodies that transmit messages. The protein stops axon growth at times when synapses form, allowing transmission of information to another nerve cell.

The research showed that gabapentin blocks the protein from putting on its brakes, which effectively allowed axons to grow longer after injury.

“There is some spontaneous recovery in untreated mice, but it’s never complete. The treated mice still have deficits, but they are significantly better,” said senior author Andrea Tedeschi, assistant professor of neuroscience at The Ohio State University.

“This research has translational implications because the drug is clinically approved and already prescribed to patients,” he said. “I think there’s enough evidence here to reconsider how we use this drug in the clinic. The implication of our finding may also impact other neurological conditions such as brain injury and stroke.”

The regained function in mice occurred after four months of treatment — the equivalent of about nine years in adult humans.

“We really have to consider that rebuilding neuronal circuits, especially in an adult central nervous system, takes time. But it can happen,” said Wenjing Sun, research assistant professor of neuroscience at Ohio State and first author of the publication.

The study is published in the Journal of Clinical Investigation.

The spinal cord injury in these mice is located near the top of the spine. Humans with this type of injury generally lose enough sensation and movement to require assistance with daily living tasks.

After receiving gabapentin for four months, the treated mice were better able to move across a horizontal ladder and spread their forelimb toes than untreated mice. When the researchers used a special technique to silence neurons in the repair pathway they had targeted, there was no difference in functional recovery between treated and untreated mice.

“Now we can comfortably say that whatever we see in terms of structural and functional alterations of this motor pathway is really meaningful in promoting recovery in these mice,” Tedeschi said.

Tedeschi noted that in this study, treatment with gabapentin occurred much earlier than is typical in human medicine, when it is prescribed to treat existing neuropathic pain and other neurological conditions.

“Gabapentin is given when the nervous system is already having issues associated with maladaptive plasticity that hinders normal function. We are giving it much, much earlier, when the nervous system may be more responsive to programming an adaptive repair process,” he said.

A retrospective study of European medical data published in 2017 showed that individuals who had received anticonvulsants — gabapentin or a similar drug — early after spinal cord injury regained motor function. It was not a clinical trial, but the analysis showed an association between taking a class of drugs called gabapentinoids and regaining muscle strength.

Plenty of questions remain: how and when to adjust the amount of gabapentin used for treatment, and whether the drug could be combined with other interventions used to promote repair of an injured spinal cord at chronic stages. But testing the effectiveness of the drug in larger animal models is a logical next step prior to embarking on clinical trials, Tedeschi said.

“With all the evidence and mechanistic insight we provide, I feel like we are in a better situation to start planning a more translational type of research,” he said. “It’s the right time to try.”

Tedeschi’s research focuses on neurons in the corticospinal tract — specifically motor neurons that carry signals from the central nervous system to the body telling muscles to move. These cells are particularly important in controlling voluntary movement, which is impaired in cervical spinal cord injuries modeled in the study.

This work builds upon the recent discovery of the regulatory role of a neuronal receptor called alpha2delta2 in controlling axon growth ability. Tedeschi and colleagues have determined that alpha2delta2 facilitates synapse formation by putting on the brake for axon growth, an essential step during the development of the central nervous system.

The researchers discovered in the current study that after a cervical spinal cord injury, affected motor neurons above the spine increased the expression of this receptor, interfering with axons’ ability to regrow. If axon repair doesn’t go as expected and neuronal circuits are reorganized improperly, individuals with spinal cord injury may experience uncontrolled movement and pain.

“When neuronal circuits need to be rebuilt after injury, we need to down-regulate the expression of the receptor so axons can re-engage in an active growth program. And we found that it’s doing exactly the opposite,” said Tedeschi, also a member of Ohio State’s Chronic Brain Injury Discovery Theme.

“Because this receptor can be pharmacologically blocked through administration of clinically approved drugs called gabapentinoids — for example, gabapentin and pregabalin — that’s a very powerful target that you can modulate as long as you take the drug.”

This research was funded by the Craig H. Neilsen Foundation, the Marina Romoli Onlus Association, the Ohio State University Neuroscience Research Institute, and grants from the National Institute of Neurological Disorders and the National Institutes of Health.

Share Button

Global carbon emissions growth slows, but hits record high

The runaway train that is climate change is about to blow past another milestone: global fossil-fuel carbon dioxide emissions will reach yet another record high. Driven by rising natural gas and oil consumption, levels of CO2 are expected to hit 37 billion tons this year, according to new estimates from the Global Carbon Project, an initiative led by Stanford University scientist Rob Jackson.

The findings are outlined in three new papers published in Earth System Science Data, Environmental Research Letters, and Nature Climate Change. Although the rate of emissions growth is slower than in the previous two years, the researchers warn emissions could increase through 2030 unless national energy, transportation and industry policies change dramatically.

“When the good news is that emissions growth is slower than last year, we need help,” said Jackson, a professor of Earth system science in Stanford’s School of Earth, Energy & Environmental Sciences (Stanford Earth). “When will emissions start to drop?”

The new projections come as international negotiators meet in Madrid for the 25th conference of the United Nations Framework Convention on Climate Change. Jackson and his colleagues make clear policymakers have their work cut out for them, estimating global carbon dioxide emissions from fossil fuel sources — which represent roughly 90 percent of all emissions from human activities — will grow a projected 0.6 percent over 2018 emissions. That compares to 2.1 percent growth a year earlier and 1.5 percent growth in 2017.

Glimmers of hope, such as the dramatic decline of coal use in the European Union and United States, are overshadowed by surging natural gas and oil use around the world, according to the researchers. Per capita emissions in affluent countries remain disproportionately high — a fact that further complicates the picture as developing countries seek greater prosperity through more natural-gas-fueled electricity and gasoline-powered vehicles and air travel.

“Emissions cuts in wealthier nations must outpace increases in poorer countries where access to energy is still needed,” said Pierre Friedlingstein, a mathematics professor at the University of Exeter and lead author of the Global Carbon Budget paper in Earth System Science Data.

Coal’s decline and natural gas’s rise

The group found that the U.S., E.U. and China account for more than half of all carbon dioxide emissions globally. While annual emissions are decreasing slowly in many industrialized regions, including the U.S., where they are down a projected 1.7 percent since last year, they are growing in many countries, including China, where they should jump 2.6 percent this year. About 40 percent of global carbon dioxide emissions were attributable to coal use, 34 percent from oil, 20 percent from natural gas, and the remaining 6 percent from cement production and other sources.

Although still a major factor in global emissions, coal has taken a hit, with global usage down 0.9 percent for the past year. In 2019, consumption of coal dropped 11 percent in the U.S. — down 50 percent from its peak in 2005 — displaced by cheaper natural gas, wind and solar power, as well as savings from energy efficiency. Coal use dropped a further 10 percent in the E.U. In China, which accounts for half of global coal use, growth slowed to 0.8 percent this year due in part to China’s economic downturn.

“Declining coal use in the U.S. and Europe is reducing emissions, creating jobs and saving lives through cleaner air,” said Jackson, who is also a senior fellow at the Stanford Woods Institute for the Environment and the Precourt Institute for Energy. “More consumers are demanding cheaper alternatives such as solar and wind power.”

Billed by some as a “bridge fuel” away from more pollutive energy sources, natural gas produces significantly fewer carbon dioxide emissions than oil or coal. Because of greater supply and cheaper prices, natural gas usage has surged, with an attendant 2.6 percent increase in carbon dioxide emissions for 2019. In fact, rising natural gas use accounts for 60 percent of fossil emissions growth in recent years.

The researchers warn that hopes for natural gas to be a bridge fuel can only come true with measures, such as carbon capture and storage, to mediate the fuel source’s emissions and a reduction in methane leakage from natural gas infrastructure.

Emissions responsibility

While some wealthier countries have made substantial progress in reducing overall emissions, per capita emissions in these countries remain stubbornly high. Around the world, the average person is responsible for about 4.8 tons of fossil carbon dioxide emissions per year. By comparison, the average person in the United States is responsible for more than three-and-a-half times that amount. Success stories, such as the E.U., where emissions have been declining about 1 percent per year are counterbalanced by the story of countries such as China, where per capita carbon dioxide emissions have grown to rival or even exceed those of the E.U.

Strong inequalities still exist, particularly in per capita oil use. U.S. oil consumption per person is 16 times greater than in India and six times greater than in China. Vehicle ownership is similarly skewed, with almost one motor vehicle per person in the United States but only one for every 40 people in India and 6 in China. A similar rate of car ownership in China or India as in the United States would put a billion new cars on the road in either country.

Light at the end of the tunnel?

To counterbalance increasing emissions, the researchers call for stronger national policies and global commitments to help institute carbon pricing, accelerate energy efficiency improvements, reduce energy consumption, deploy electric vehicles, ramp up carbon capture and storage technologies and replace fossil fuels with renewable sources.

More than 18 countries have found a way to expand their economies over the past decade while reducing carbon dioxide emissions, according to an earlier study that included co-authors affiliated with the Global Carbon Project. The countries include the United Kingdom and Denmark, which coupled stable or declining energy use with new renewable fuel capacity that displaced fossil fuel use.

“We need every arrow in our climate quiver,” Jackson said. “That means stricter fuel efficiency standards, stronger policy incentives for renewables, even dietary changes and carbon capture and storage technologies.”

Share Button

Diabetes drug has unexpected, broad implications for healthy aging

Metformin is the most commonly prescribed type 2 diabetes drug, yet scientists still do not fully know how it works to control blood sugar levels. In a collaborative effort, researchers from the Salk Institute, The Scripps Research Institute and Weill Cornell Medical College have used a novel technology to investigate why it functions so well. The findings, which identified a surprising number of biochemical “switches” for various cellular processes, could also explain why metformin has been shown to extend health span and life span in recent studies. The work was published in Cell Reports on December 3, 2019.

“These results provide us with new avenues to explore in order to understand how metformin works as a diabetes drug, along with its health-span-extending effects,” says Professor Reuben Shaw, co-corresponding author of the paper and the director of Salk’s NCI-designated Cancer Center. “These are pathways that neither we, nor anyone else, would have imagined.”

Previously, the only biochemical pathway that was known to be activated by metformin was the AMPK pathway, which Shaw discovered stalls cell growth and changes metabolism when nutrients are scarce, as can occur in cancer. But the scientists believed more pathways than AMPK might be involved.

The scientists developed a novel screening platform to examine kinases, the proteins that transfer phosphate groups, which are critical on/off switches in cells and can be rapidly flipped by metformin. Using this technology, the researchers were able to decode hundreds of regulatory “switch-flipping” events that could affect healthy aging.

“Being mentored by John Yates, one of the top mass spectrometry investigators in the world, and Reuben Shaw, an expert in the field of metabolism, enabled me to both develop and apply a novel technology to a critical biological question: What pathways are regulated by metformin in the liver?” says Ben Stein, first author and postdoctoral associate at Weill Cornell Medical College.

The results revealed that metformin turns on unexpected kinases and pathways, many independent of AMPK. Two of the activated kinases are called Protein Kinase D and MAPKAPK2. These kinases are poorly understood, but are known to have some relation to cellular stress, which could connect them to the health-span- and life-span-extending effects observed in other studies. In fact, metformin is currently being tested in multiple large-scale clinical trials as a health-span- and life-span-extending drug, but the mechanism for how metformin could affect health and aging has not been clear. The current study indicates that Protein Kinase D and MAPKAPK2 may be two players in providing these therapeutic effects, and identifies new targets and cellular processes regulated by AMPK that may also be critical to metformin’s beneficial effects.

“We never imagined these two kinases would have anything to do with metformin,” says Shaw, holder of the William R. Brody Chair. “The results broaden our understanding of how metformin induces a mild stress that triggers sensors to restore metabolic balance, explaining some of the benefits previously reported such as extended healthy aging in model organisms taking metformin. The big questions now are what targets of metformin can benefit the health of all individuals, not just type 2 diabetics.”

Next, the researchers plan to examine the new signaling pathways they discovered in more detail to better understand the beneficial effects of metformin.

Story Source:

Materials provided by Salk Institute. Note: Content may be edited for style and length.

Share Button

Samoa measles: Unvaccinated families told to hang red flag on door

The Pacific nation declares a state of emergency as 60 people die of measles.

Share Button

10 Self-Care Moves You Can Do at Your Desk

[brightcove:5624850626001 default]

Self care is all about taking care of your mind and body, so you feel less stress and more joy. Considering the hectic pace of the work world, most of us could benefit from more self-care during the workday—to crank up productivity, form stronger relationships with coworkers, and ace performance, says psychotherapist Suzie DeVaughn, owner of Self-Care Specialists in Wichita, Kansas.

If you already have a self-care routine at home or at the gym, then you know how it can make you feel happier and more in tune with yourself and your needs. So try incorporating these expert-backed easy moves into your workday as well. They'll help you shake off motivation killers like anxiety and stress and give you the tools to thrive from nine to five.

RELATED: Laverne Cox Has the Most Unique Self-Care Routine We've Ever Heard

Nourish yourself at lunch

With breakfast the most important meal of the day and dinner a time for reconnecting with loved ones, lunch tends to get short shrift. (They don't call it a sad desk salad for nothing, right?) Instead of wolfing down another on-the-fly veggie bowl or sandwich, make your midday meal more of an opportunity for nourishment. Pack or order foods you love that offer energizing protein and complex carbs, which can put you in a brighter mood and help you power through the afternoon. 

Check out a #funny site

Chase away stress by scrolling through the latest adorable animal viral video at @cutepetclub or watching a Saturday Night Live clip on YouTube you missed over the weekend. Laughing can prompt the release of the feel-good hormones endorphins and in turn make you feel more relaxed and revived. Even a few minutes in the break room with a coworker whose stories always crack you up will do the trick. 

Get up, stretch, and move

Stretch your arms and legs at your desk, do laps around the office, walk up and down the stairs, or take on some other activity that allows you to move your body. “When we start to feel our body signaling that we need a break, stepping out of your workspace for 5 to 10 minutes can help shift perspective and gain mental clarity,” says DeVaughn. “Running quick errands, going to make coffee or tea, or visiting with a co-worker are very helpful for rejuvenation.”

If you can get outside at some point during your workday, go for it: A 2017 study echoed previous research, finding that exposure to sounds found in nature has a soothing effect on the heart and brain.

Calm yourself with essential oils

Lavender, wild orange, and bergamot therapeutic-grade essential oils can relax and uplift you, says Krista-Lynn Landolfi, life coach and self-care specialist. Hiding a small stash of these in your desk drawer and occasionally dousing some on a cotton ball you can sniff will help revive your spirits without disturbing others sitting next to you. (But ask your deskmates if they have a hypersensitivity or allergy to these oils before you use them, just in case.)

Declutter and decorate 

A messy environment can intensify the tension and anxiety you already feel, says DeVaughn. No need to be a super organized neat freak if that's not your natural style. And yep, today's open-concept workplaces don't give even high-up employees much room to personalize. But take some time every week to organize your workspace and decorate it with family or pet photos, artwork that resonates with you, or quotes that inspire you. 

RELATED: 15 Ways to Add Self-Care to Your Workout Routine

Snack smartly

Vending machine runs are convenient, but you know that diet soda and sweet treats aren't exactly the best snack choices when you're racing against a deadline or feeling overwhelmed by a report. “When people are filling themselves with caffeine and sugar, it's going to give them a frenetic energy and create an ultimate crash,” explains Landolfi. Avoid that by opting for high protein nuts, filling air-popped popcorn, or a healthy smoothie.

RELATED: What Is High-Functioning Anxiety–and Could You Have It?

Repeat an inspiring mantra

The way we talk to ourselves shapes our performance and attitude. It's a good reason to come up with a go-to saying or a list of affirmations to recite out loud (or quietly to yourself) when you’re feeling doubtful or need a confidence boost, suggests DeVaughn. “I am the Beyoncé of this office" has a powerful ring to it, as does “I will succeed on this project with ease."

Take 3 deep breaths

You've heard that inhaling deeply can help energize and calm you. But Landolfi is a fan of a breathing exercise called "three to be free" breathing. Three times a day, stop what you're doing and take three deep breaths to free the tension, stress, and worry that has been build throughout the workday, she says. What makes this self-care move so good for work is that you can do it discreetly while you're sitting at your desk, and even your closest cubicle neighbor won't be disturbed.

RELATED: 9 Self-Care Gifts You Can Buy Yourself on Amazon

Speak out in a meeting

Doing something bold—writing a memo outlining your concerns over a new project, for example, or volunteering to take on a client who you know will challenge you—can put you back on your A game at the office. Why's that? Accomplishing something that you once feared can give you the adrenaline rush that you need to finish the day strong, says Landolfi. You'll feel more a part of your team and more invested in your work.

Pat yourself on the back

Take stock of what you've accomplished on the job once a week or so—and congratulate yourself for your efforts and anything you've done to boost the bottom line or improve performance. Reminding yourself of your contributions gives you a psychological boost and helps you feel more positive, which is the ultimate goal of self care.

To get our best wellness tips delivered to you inbox, sign up for the Healthy Living newsletter

Share Button

Miroslava Duma Reveals She Has Rare Lung Disease: ‘I Was Given 7 Months to Live’

Miroslava Duma has let her 1.6 million Instagram followers into a pretty major secret: she has been battling a rare lung disease. In a lengthy post on Sunday, she revealed that she was given just 7 months to live when she was diagnosed earlier this year.

“It was crazy scary then, but looking back, I realise that the past few months of recovery were possibly the happiest months of my entire life,” the fashion influencer and businesswoman wrote alongside a photograph of herself.

In the US, a rare disease is defined by the National Institutes of Health Office of Rare Diseases as one that affects fewer than 200,000 people; however, it is estimated that at least 1 to 2 million Americans suffer from rare lung diseases. It’s not clear what specific disease Duma has (or if she still has it), what treatment she has received, or when exactly she was diagnosed.

RELATED: These 3 Women Were Each Diagnosed With Advanced Lung Cancer—Even Though They Never Smoked

What is clear from her Instagram post is that the experience has been life-changing.

“I suddenly stopped running the marathon and realised how much I love life, how beautiful our world is and how much I want to stay here—with the people I love,” wrote the 34-year-old mom of three, who is married to fellow entrepreneur Aleksey Mikheev. “For the first time in my life, I saw the bright blue of skies. And the beautiful green of trees. As if I had lived on a different planet before. I wake up happy, just because I can spend one more day here.”

Duma went on to say that she has shifted her mentality and is no longer concerned about external validation. “My entire life I was seeking approval and obsessing over ‘likes’ both in physical and virtual worlds, without realising that I actually had to learn how to ‘like’ myself first,” she wrote. “Success to me today is not measured by external indicators anymore, but by what’s inside. It is measured by my own health, and the health of those I love.”

RELATED: 7 Causes of Lung Cancer in Nonsmokers

She believes her busy, high-pressure lifestyle was partly to blame for her poor health. “Years of self-criticism and doubt, stress, dieting, physically, mentally and emotionally pushing and pushing myself got my immune system to collapse and I had made myself fatally sick,” she shared. “I now realise that these past months were almost the most creative months of my entire 34 years."

She finished the post by thanking the “wonderful people” in her life, adding, “I love you with all of my heart (and my lungs).”

RELATED: This Woman Thought She Had Pneumonia—but It Turned Out to Be Stage 4 Lung Cancer

Duma was a regular on the fashion scene in the early 2000s, regularly photographed at New York and Paris Fashion Weeks. She served as project director at Harper’s Bazaar and has also freelanced for the Russian editions of Vogue, Forbes Woman and Glamour.

In 2011, she founded Buro 24/7, a website devoted to art, film, fashion, and music, and in 2017, she founded Future Tech Lab, an investment and technology company.

To get our top stories delivered to your inbox, sign up for the Healthy Living newsletter

Share Button